Distinct urinary glycoprotein signatures in prostate cancer patients (2018)
- Authors:
- USP affiliated authors: SROUGI, MIGUEL - FM ; LEITE, KATIA RAMOS MOREIRA - FM ; PALMISANO, GIUSEPPE - ICB
- Unidades: FM; ICB
- DOI: 10.18632/oncotarget.26005
- Subjects: PARASITOLOGIA; GLICOPROTEÍNAS; NEOPLASIAS; PRÓSTATA; BIOMARCADORES
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: OncoTarget
- ISSN: 1949-2553
- Volume/Número/Paginação/Ano: V. 9, N. 69, P. 33077-33097, 2018
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
KAWAHARA, Rebeca et al. Distinct urinary glycoprotein signatures in prostate cancer patients. OncoTarget, 2018Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.26005. Acesso em: 17 fev. 2026. -
APA
Kawahara, R., Ortega, F., Rosa-Fernandes, L., Guimarães, V., Quina, D., Nahas, W., et al. (2018). Distinct urinary glycoprotein signatures in prostate cancer patients. OncoTarget. doi:10.18632/oncotarget.26005 -
NLM
Kawahara R, Ortega F, Rosa-Fernandes L, Guimarães V, Quina D, Nahas W, Schwämmle V, Srougi M, Leite KRM, Thaysen-Andersen M, Larsen MR, Palmisano G. Distinct urinary glycoprotein signatures in prostate cancer patients [Internet]. OncoTarget. 2018 ;[citado 2026 fev. 17 ] Available from: https://doi.org/10.18632/oncotarget.26005 -
Vancouver
Kawahara R, Ortega F, Rosa-Fernandes L, Guimarães V, Quina D, Nahas W, Schwämmle V, Srougi M, Leite KRM, Thaysen-Andersen M, Larsen MR, Palmisano G. Distinct urinary glycoprotein signatures in prostate cancer patients [Internet]. OncoTarget. 2018 ;[citado 2026 fev. 17 ] Available from: https://doi.org/10.18632/oncotarget.26005 - Tissue proteome signatures associated with five grades of prostate cancer and benign prostatic hyperplasia
- Protein paucimannosylation is an enriched N-gycosylation signature of human cancers
- Treating metastatic prostate cancer with microRNA-145
- PD-L1 expression in renal cell carcinoma clear cell type is related to unfavorable prognosis
- Prognostic value of TERF1 expression in prostate cancer
- Controlling RECK miR21 promotes tumor cell invasion and is related to biochemical recurrence in prostate cancer
- Upregulation of shelterin and CST genes and longer telomeres are associated with unfavorable prognostic characteristics in prostate cancer
- Histologic abnormalities in non-neoplastic renal parenchyma and the risk of chronic kidney disease following radical nephrectomy
- Shorter leukocyte telomere length is associated with severity of COVID-19 infection.
- Pan-cancer analysis reveals that CTC1-STN1-TEN1 (CST) complex may have a key position in oncology
Informações sobre o DOI: 10.18632/oncotarget.26005 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
